News | Cardiovascular Clinical Studies | February 07, 2022

Study: Cognitive Assessments Can Help Track Cardio Risk

Study enrolled and assessed 239 older adults in a proof-of-concept trial to determine if novel, remotely-administered, cognitive assessments could detect the known association between cognitive performance and cardiovascular risk factors

A new study is the first to show that a remote cognitive assessment could help with tracking patients with cardiovascular risk. Getty Images

Getty Images


February 8, 2022  A new study is the first to show that a remote cognitive assessment could help with tracking patients with cardiovascular risk. The assessments evaluated are from Posit Science, which makes the BrainHQ brain exercise app.
 
Prior studies have established that people with cardiovascular risk factors are at increased risk for cognitive decline and dementia as they age. However, such studies have relied on the gold standard of in-person neuropsychological testing, which, while very beneficial, can be time-consuming, expensive, and challenging to arrange during a pandemic.
 
The Health eBrain Study, published in JMIR Formative Research, enrolled and assessed 239 older adults in a proof-of-concept trial to determine if novel, remotely-administered, cognitive assessments could detect the known association between cognitive performance and cardiovascular risk factors. Remote testing could provide a means for identifying people who are suffering from cognitive issues associated with their cardiovascular risk factors, and could provide a tool for monitoring their brain health in an ongoing way.
 
Researchers from the University of California San Francisco, The Neurology Center of Southern California, and Posit Science found that participants with the cardiovascular risk factors atrial fibrillation and hypertension had significantly worse performance on memory assessments used in the study. 
 
The researchers noted the results suggest such “assessments can be used to detect the association between cardiovascular risk factors and cognition function,” and that the “ability to remotely track cognitive health in individuals with modifiable cardiovascular risk factors could represent a unique opportunity to target high-risk individuals for early education, frequent monitoring, and interventions with the hope of preventing accelerated cognitive decline with aging.”
 
Prior studies of people with chronic heart failure have found using BrainHQ exercises (from which these assessments were derived) can improve health outcomes, mobility, and patient self-care management, and can reduce healthcare costs.
 
“This study represents another step toward a world in which patients can both monitor and improve brain health, with an app you can carry in your pocket,” said Dr. Henry Mahncke, Posit Science CEO. “It also raises the possibility that health systems and providers could identify patients with cardiovascular risk factors based on their remotely-administered brain health assessments, as well as monitor the cognitive ability of patients with such risk factors.”
 
BrainHQ exercises have been shown effective in hundreds of studies across varied populations, with benefits that include gains on standard measures of cognition (attention, speed, memory, decision-making), and quality of life (mood, self-rated health, health-related quality of life), as well as in real-world activities (gait/balance, driving, listening, work). BrainHQ is available, without charge to users, through leading Medicare Advantage plans, retirement communities, libraries, medical centers, and employers.
 
For more information: brainhq.com

Related Content

News | Cardiovascular Clinical Studies

May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a ...

Home May 11, 2022
Home
News | Cardiovascular Clinical Studies

May 5, 2022 — High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a ...

Home May 05, 2022
Home
News | Cardiovascular Clinical Studies

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

Home April 07, 2022
Home
News | Cardiovascular Clinical Studies

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

Home April 06, 2022
Home
News | Cardiovascular Clinical Studies

March 25, 2022 – Despite recent efforts to improve women’s leadership in cardiovascular clinical trial research over the ...

Home March 25, 2022
Home
News | Cardiovascular Clinical Studies

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case ...

Home February 17, 2022
Home
News | Cardiovascular Clinical Studies

June 24, 2021 — Data captured in American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) ...

Home June 24, 2021
Home
News | Cardiovascular Clinical Studies

January 27, 2021 — A New York Institute of Technology research team has secured a five-year $1.8 million grant from the ...

Home January 27, 2021
Home
News | Cardiovascular Clinical Studies

July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to ...

Home July 22, 2020
Home
News | Cardiovascular Clinical Studies

July 1, 2020 — Carag AG announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption ...

Home July 01, 2020
Home
Subscribe Now